Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Debt / NOTE 2.750% 7/1
-
Market price (% of par)
-
75.39%
-
Total 13F principal
-
$380,406,110
-
Principal change
-
-$9,176,890
-
Total reported market value
-
$289,898,000
-
Number of holders
-
40
-
Value change
-
-$5,149,312
-
Number of buys
-
17
-
Number of sells
-
17
Institutional Holders of MEDICINES CO - NOTE 2.750% 7/1 as of Q4 2018
As of 31 Dec 2018,
MEDICINES CO - NOTE 2.750% 7/1 was held by
40 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$380,406,110
in principal (par value) of the bond.
The largest 10 bondholders included
Partner Fund Management, L.P., CAPSTONE INVESTMENT ADVISORS, LLC, UBS OCONNOR LLC, AMUNDI PIONEER ASSET MANAGEMENT INC, Allianz Asset Management GmbH, MACKAY SHIELDS LLC, Invesco Ltd., CITADEL ADVISORS LLC, CALAMOS ADVISORS LLC, and AMERIPRISE FINANCIAL INC.
This page lists
40
institutional bondholders reporting positions
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.